FIELD: biotechnological methods.
SUBSTANCE: invention is intended for use in, food processing, cosmetics, biotechnological, medicinal industries, and veterinary in order to strengthen health, in particular when preparing lactic fermented and non-fermented food products, cosmetics, biologically active additives, and probiotic. Strain Bifidobacterium lactis 672 BKPM As-1677 is isolated from contents of healthy baby bowels. Invention enhances biological activity of the strain and its resistance to environmental conditions, accelerates growth on artificial nutrient media and acid-forming and antagonistic activity with regard to pathogenic and conditionally pathogenic microflora. Preparation of strains possessing above properties promotes extension of assortment of probiotics used to maintain health, in particular to normalize microflora gastroenteric and urogenital tracts, human and animal cutaneous coverings and mucous membranes.
EFFECT: increased assortment of bacterial preparations.
2 tbl, 6 ex
Authors
Dates
2007-03-27—Published
2005-02-22—Filed